|
GNL3L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.835100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.208300E-04 |
| Normal-vs-Stage2 |
6.931600E-01 |
| Normal-vs-Stage3 |
8.304000E-01 |
| Normal-vs-Stage4 |
1.064030E-01 |
| Stage1-vs-Stage2 |
2.811800E-01 |
| Stage1-vs-Stage3 |
5.395700E-02 |
| Stage1-vs-Stage4 |
8.517800E-01 |
| Stage2-vs-Stage3 |
6.379600E-01 |
| Stage2-vs-Stage4 |
3.919200E-01 |
| Stage3-vs-Stage4 |
1.939370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.665630E-02 |
| Normal-vs-AfricanAmerican |
2.037900E-03 |
| Normal-vs-Asian |
1.945790E-02 |
| Caucasian-vs-AfricanAmerican |
2.611800E-01 |
| Caucasian-vs-Asian |
4.780400E-01 |
| AfricanAmerican-vs-Asian |
6.949800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.799610E-04 |
| Normal-vs-Female |
4.553800E-01 |
| Male-vs-Female |
3.211100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.018300E-02 |
| Normal-vs-Extreme_Weight |
4.36839999999883E-05 |
| Normal-vs-Obese |
4.751800E-01 |
| Normal-vs-Extreme_Obese |
1.780250E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.785560E-01 |
| Normal_Weight-vs-Obese |
3.290000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.199600E-01 |
| Extreme_Weight-vs-Obese |
1.119810E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.881200E-01 |
| Obese-vs-Extreme_Obese |
1.338780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.618000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.501040E-01 |
| Normal-vs-Age(61-80Yrs) |
5.152800E-04 |
| Normal-vs-Age(81-100Yrs) |
4.076000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.898600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.209500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.114410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.312200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.836810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.869800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.990600E-04 |
| Normal-VS-Type2 PRCC |
6.283700E-02 |
| Normal-VS-KIRP CIMP |
2.274400E-01 |
| Normal-VS-Unclassified PRCC |
9.913200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.813400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.992400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.076100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.197900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.872950E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.665610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.960100E-02 |
| Normal-vs-N1 |
6.795600E-01 |
| Normal-vs-N2 |
7.313800E-01 |
| N0-vs-N1 |
7.498000E-02 |
| N0-vs-N2 |
7.445800E-01 |
| N1-vs-N2 |
6.253800E-01 |
|
|
